Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-07-23 20:43 CEST (UTC+2h)
 

EMA Product Specific GL [Regulatives / Guidelines]

posted by mmw - India, 2017-07-14 14:50  - Posting: # 17548
Views: 186

Dear all,

EMA adopted a new batch of product specific guidances. Published on 10/07/2017:

Crizotinib
Elvitegravir / cobicistat / emtricitabine / te­no­fovir disoproxil
Elvitegravir
Emtricitabine, rilpivirine, tenofovir, disopro­xil
Vortioxetine

Thanks

MMW

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,098 Posts in 3,667 Threads, 1,051 registered users;
15 users online (0 registered, 15 guests).

They must find it difficult… those who have taken authority as the truth,
rather than truth as the authority.    Gerald Massey

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed